A diagnostic autoantibody signature for primary cutaneous melanoma.

Zaenker, Pauline; Lo, Johnny; Pearce, Robert; Cantwell, Phillip; Cowell, Lester; Lee, Mark; Quirk, Christopher; Law, Henry; Gray, Elin; Ziman, Mel

Zaenker, Pauline; Lo, Johnny; Pearce, Robert; Cantwell, Phillip; Cowell, Lester; Lee, Mark; Quirk, Christopher; Law, Henry; Gray, Elin; Ziman, Mel.

Afiliação

Zaenker P; School of Medical and Health Sciences, Edith Cowan University, Joondalup, Perth, WA, Australia.
Lo J; School of Science, Edith Cowan University, Joondalup, Perth, WA, Australia.
Pearce R; Hollywood Specialist Centre, Hollywood Private Hospital, Nedlands, Perth, WA, Australia.
Cantwell P; Hollywood Specialist Centre, Hollywood Private Hospital, Nedlands, Perth, WA, Australia.
Cowell L; Level 1 Melanoma, Fremantle, Perth, WA, Australia.
Lee M; St John of God Hospital, Subiaco, Perth, WA, Australia.
Quirk C; Dermatology Specialist Group, Ardross, Perth, WA, Australia.
Law H; Skin Check WA, Inglewood, Perth, WA, Australia.
Gray E; School of Medical and Health Sciences, Edith Cowan University, Joondalup, Perth, WA, Australia.
Ziman M; School of Medical and Health Sciences, Edith Cowan University, Joondalup, Perth, WA, Australia.

Oncotarget ; 9(55): 30539-30551, 2018 Jul 17.

Article em En | MEDLINE | ID: mdl-30093967

Palavras-chave

autoantibody; biomarker; diagnosis; melanoma; microarray

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Screening_studies Idioma: En Revista: Oncotarget Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Austrália

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google